Efficacy and safety of a new medicated nail hydrolacquer in the treatment of adults with toenail onychomycosis: A randomised clinical trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of a new medicated nail hydrolacquer in the treatment of adults with toenail onychomycosis: A randomised clinical trial

Published:2022-11-17 Issue: Volume: Page:
ISSN:0933-7407
Container-title:Mycoses
language:en
Short-container-title:Mycoses

Author:

Zalacain‐Vicuña Antonio J.¹^ORCID,Nieto Carlos²,Picas Jordi²,Martínez Helena²^ORCID,Bermejo Rafael²,Corrales Adrián²,Campos Francisco Fernández²,Igea Soledad Anguiano³,Otero‐Espinar Francisco Javier³⁴,Briones Vicente García‐Patos⁵^ORCID

Affiliation:

1. Podiatry School. Faculty of Medicine and Health Sciences University of Barcelona L'Hospitalet de Llobregat Spain

2. Laboratorio Reig Jofre Barcelona Spain

3. Department of Pharmacology, Pharmacy and Pharmaceutical Technology University of Santiago de Compostela Santiago de Compostela Spain

4. Institute of Materials iMATUS. University of Santiago de Compostela Santiago de Compostela Spain

5. Department of Dermatology Hospital Universitari Vall d'Hebron, UAB (Autonomous University of Barcelona) Barcelona Spain

Publisher

Wiley

Subject

Infectious Diseases,Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/myc.13543

Reference36 articles.

1. Understanding the formidable nail barrier: A review of the nail microstructure, composition and diseases

2. Epidemiology and clinical classification of onychomycosis

3. The Dermatologist’s Approach to Onychomycosis

4. Estrategias terapéuticas en las onicomicosis

5. Antifungal agents for onychomycosis: new treatment strategies to improve safety

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP